ruboxistaurin has been researched along with Myocardial Infarction in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ge, ZD; Irwin, MG; Jin, J; Lei, S; Li, H; Liao, S; Liu, Y; Qiao, S; Wong, GT; Xia, Z | 1 |
Chen, X; Houser, SR; Kranias, EG; Leitges, M; Liu, Q; Lorenz, JN; Macdonnell, SM; Molkentin, JD | 1 |
Correll, RN; Hajjar, RJ; Houser, SR; Ishikawa, K; Kawase, Y; Ladage, D; Molkentin, JD; Tilemann, L | 1 |
Belmonte, SL; Blaxall, BC | 1 |
Boyle, AJ; Cox, AJ; Gilbert, RE; Gow, RM; Itescu, S; Kelly, DJ; Krum, H; Way, K; Zhang, Y | 1 |
5 other study(ies) available for ruboxistaurin and Myocardial Infarction
Article | Year |
---|---|
Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.
Topics: Animals; Apoptosis; Caveolin 3; Cell Line; Diabetes Mellitus, Experimental; Dinoprost; Enzyme Activation; Indoles; Isoprostanes; Male; Maleimides; Membrane Potential, Mitochondrial; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphorylation; Phthalimides; Protein Kinase C beta; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Time Factors; Transfection; Ventricular Function, Left | 2015 |
Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.
Topics: Adrenergic beta-Antagonists; Animals; Calcium Signaling; Cardiomegaly; Disease Models, Animal; Fibrosis; Heart Failure; Indoles; Maleimides; Metoprolol; Mice; Mice, Knockout; Myocardial Contraction; Myocardial Infarction; Myocardium; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Protein Kinase Inhibitors; Pulmonary Edema; Time Factors | 2009 |
Inhibition of PKCα/β with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury.
Topics: Animals; Cardiac Output; Coronary Occlusion; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Heart; Heart Failure; Indoles; Maleimides; Myocardial Contraction; Myocardial Infarction; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Pyrroles; Stroke Volume; Swine | 2011 |
PKC-ing is believing: targeting protein kinase C in heart failure.
Topics: Animals; Enzyme Inhibitors; Female; Heart Failure; Indoles; Maleimides; Myocardial Infarction; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha | 2011 |
Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction.
Topics: Animals; Collagen; Echocardiography; Extracellular Matrix; Fibrosis; Gene Expression Regulation; Heart Ventricles; In Situ Hybridization; Indoles; Male; Maleimides; Myocardial Infarction; Protein Kinase C; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ventricular Dysfunction, Left | 2005 |